Psoriatic Arthritis Treatment Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Psoriatic Arthritis Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Psoriatic Arthritis Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Psoriatic Arthritis Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Psoriatic Arthritis Treatment Market By Drug Class
1.2.3. Psoriatic Arthritis Treatment Market By Product Type
1.2.4. Psoriatic Arthritis Treatment Market By Distribution Channel
1.2.5. Psoriatic Arthritis Treatment Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.1.3. Driver 3
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.2.3. Restraint 3
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.3.3. Opportunity 3
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Psoriatic Arthritis Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Psoriatic Arthritis Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Psoriatic Arthritis Treatment Market By Drug Class
5.1. Introduction
5.2. Psoriatic Arthritis Treatment Revenue By Drug Class
5.2.1. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast, By Drug Class, 2020-2032
5.2.2. DMARD
5.2.2.1. DMARD Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. NSAIDs
5.2.3.1. NSAIDs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Biologics
5.2.4.1. Biologics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Psoriatic Arthritis Treatment Market By Product Type
6.1. Introduction
6.2. Psoriatic Arthritis Treatment Revenue By Product Type
6.2.1. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast, By Product Type, 2020-2032
6.2.2. OTC
6.2.2.1. OTC Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Prescriptions
6.2.3.1. Prescriptions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Psoriatic Arthritis Treatment Market By Route of Administration
7.1. Introduction
7.2. Psoriatic Arthritis Treatment Revenue By Route of Administration
7.2.1. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast, By Route of Administration, 2020-2032
7.2.2. Oral
7.2.2.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Topical
7.2.3.1. Topical Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Injectable
7.2.4.1. Injectable Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Psoriatic Arthritis Treatment Market By Distribution Channel
8.1. Introduction
8.2. Psoriatic Arthritis Treatment Revenue By Distribution Channel
8.2.1. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
8.2.2. Hospital Pharmacies
8.2.2.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Retail Pharmacies
8.2.3.1. Retail Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Online Pharmacies
8.2.4.1. Online Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Psoriatic Arthritis Treatment Market By Country
9.1. North America Psoriatic Arthritis Treatment Market Overview
9.2. U.S.
9.2.1. U.S. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.2.2. U.S. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.2.3. U.S. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.2.4. U.S. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Canada
9.3.1. Canada Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.3.2. Canada Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.3.3. Canada Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.3.4. Canada Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Psoriatic Arthritis Treatment Market By Country
10.1. Europe Psoriatic Arthritis Treatment Market Overview
10.2. U.K.
10.2.1. U.K. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.2.2. U.K. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.2.3. U.K. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.2.4. U.K. Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Germany
10.3.1. Germany Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.3.2. Germany Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.3.3. Germany Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.3.4. Germany Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. France
10.4.1. France Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.4.2. France Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.4.3. France Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.4.4. France Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Spain
10.5.1. Spain Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.5.2. Spain Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.5.3. Spain Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.5.4. Spain Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.6.2. Rest of Europe Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.6.3. Rest of Europe Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.6.4. Rest of Europe Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Psoriatic Arthritis Treatment Market By Country
11.1. Asia Pacific Psoriatic Arthritis Treatment Market Overview
11.2. China
11.2.1. China Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.2.2. China Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.2.3. China Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.2.4. China Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. Japan
11.3.1. Japan Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.3.2. Japan Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.3.3. Japan Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.3.4. Japan Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. India
11.4.1. India Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.4.2. India Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.4.3. India Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.4.4. India Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Australia
11.5.1. Australia Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.5.2. Australia Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.5.3. Australia Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.5.4. Australia Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.6. South Korea
11.6.1. South Korea Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.6.2. South Korea Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.6.3. South Korea Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.6.4. South Korea Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.7.2. Rest of Asia-Pacific Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.7.3. Rest of Asia-Pacific Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.7.4. Rest of Asia-Pacific Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Psoriatic Arthritis Treatment Market By Country
12.1. Latin America Psoriatic Arthritis Treatment Market Overview
12.2. Brazil
12.2.1. Brazil Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.2.2. Brazil Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
12.2.3. Brazil Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.2.4. Brazil Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.3. Mexico
12.3.1. Mexico Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.3.2. Mexico Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
12.3.3. Mexico Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.3.4. Mexico Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.4.2. Rest of Latin America Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
12.4.3. Rest of Latin America Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.4.4. Rest of Latin America Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Psoriatic Arthritis Treatment Market By Country
13.1. Middle East & Africa Psoriatic Arthritis Treatment Market Overview
13.2. GCC
13.2.1. GCC Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
13.2.2. GCC Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
13.2.3. GCC Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.2.4. GCC Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.3. South Africa
13.3.1. South Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
13.3.2. South Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
13.3.3. South Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.3.4. South Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
13.4.2. Rest of Middle East & Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Product Type, 2020-2032
13.4.3. Rest of Middle East & Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.4.4. Rest of Middle East & Africa Psoriatic Arthritis Treatment Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Psoriatic Arthritis Treatment Market
14.1. Psoriatic Arthritis Treatment Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Psoriatic Arthritis Treatment Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. AstraZeneca plc
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2023
15.1.3.2. AstraZeneca plc, 2023 Psoriatic Arthritis Treatment Business Regional Distribution
15.1.4. Product /Product Type and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Pfizer Inc.
15.3. Amgen Inc.
15.4. Bausch Health Companies Inc.
15.5. Bristol-Myers Squibb Corporation
15.6. Novartis International AG
15.7. Johnson & Johnson Services Inc.
15.8. Celgene Corporation
15.9. AbbVie Inc
15.10. Eli Lilly and Company
Frequently Asked Questions
How big is the psoriatic arthritis treatment market?
The psoriatic arthritis treatment market size was valued at USD 10.8 billion in 2023.
What is the CAGR of the global psoriatic arthritis treatment market from 2024 to 2032?
The CAGR of Psoriatic Arthritis Treatment is 9.4% during the analysis period of 2024 to 2032.
Which are the key players in the psoriatic arthritis treatment market?
The key players operating in the global market are including AstraZeneca plc, Pfizer Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Corporation, Novartis International AG, Johnson & Johnson Services Inc., Celgene Corporation, AbbVie Inc., and Eli Lilly and Company
Which region dominated the global psoriatic arthritis treatment market share?
North America held the dominating position in psoriatic arthritis treatment industry during the analysis period of 2024 to 2032.
Which region registered fastest growing CAGR from 2024 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of psoriatic arthritis treatment during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global psoriatic arthritis treatment industry?
The current trends and dynamics in the psoriatic arthritis treatment industry include increasing prevalence of psoriatic arthritis worldwide, advancements in biologics and targeted therapies, and growing patient awareness and early diagnosis.
Which drug class held the maximum share in 2023?
The DMARD drug class held the maximum share of the psoriatic arthritis treatment industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
